Nikolay Savchuk
Fortune : 212 322 $ au 30/06/2026
Fortune : 212 322 $ au 30/06/2026
Nikolay Savchuk is the founder of Torrey Pines Investment, Inc. (founded in 2002) serving as Managing Member; founder of Teal Ventures Management LLC (founded in 2018) serving as Partner; and founder of Trawsfynydd Therapeutics, Inc. (founded in 2021) serving as Chief Operating Officer & Director.
Current jobs include Chairman, Chief Executive Officer & Secretary at Chromis Therapeutics, Inc.; Chief Executive Officer & Director at Mondego Bio Lda.
; President & Chief Executive Officer at Eil Therapeutics, Inc. since 2020; Chief Executive Officer at Dinas Therapeutics, Inc. since 2022; Chairman at ChemDiv, Inc. since 2022; Chairman at Chemical Diversity Research Institute CJSC; Chairman at Viriom Ltd.; Chairman at TeaRx Ltd.; Chairman at NewVac LLC; Chairman at Viriom, Inc. since 2009; Director at Avineuro Pharmaceuticals, Inc.; Director-Strategic Development at Moscow Institute of Physics & Technology; Director at ChemRar High-Tech Center; Director at Alla Chem LLC; Chief Operating Officer & Director at Traws Pharma, Inc. since 2024; President, Chief Operating Officer & Director at Lomond Therapeutics Holdings, Inc. since 2024; Partner at Teal Ventures LP Fund I LP since 2018; Chief Executive & Financial Officer at Ness Therapeutics, Inc.; and President & Chief Operating Officer at Eilean Therapeutics LLC since 2022.
Former jobs include Chief Executive Officer at Brenig Therapeutics, Inc.; President, Chief Executive Officer & Director at Lomond Therapeutics, Inc. from 2020 to 2024; Chairman at SatRx LLC; Director at Avelas Biosciences, Inc.; and Chief Executive & Financial Officer at Bala Therapeutics, Inc. Education includes a graduate degree earned in 1994 and a doctorate earned in 2000 from Moscow Institute of Physics & Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TRAWS PHARMA, INC. 1,66% | 09/07/2026 | 251 227 ( 1,66% ) | 211 784 $ | 30/06/2026 |
TRAWS PHARMA, INC. 6,16% | 01/05/2026 | 638 ( 6,16% ) | 538 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRAWS PHARMA, INC. | Directeur des opérations | 01/04/2024 |
Viriom Ltd.
Viriom Ltd. Medical/Nursing ServicesHealth Services Develops targeted medicines for HIV/AIDS treatment | Président | 19/11/2010 |
Viriom, Inc.
Viriom, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antiviral and cancer medicines | Président | 01/11/2009 |
Teal Ventures LP Fund I LP
Teal Ventures LP Fund I LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/10/2018 |
Eilean Therapeutics LLC
Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in discovery and development of small molecule inhibitors therapies for hematological cancers | President | 01/09/2022 |
Venetian-1 Acquisition Corp.
Venetian-1 Acquisition Corp. Pharmaceuticals: MajorHealth Technology Develops medicines for hematological malignancies | President | 01/11/2024 |
Trawsfynydd Therapeutics, Inc.
Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing antiviral medicines | Fondateur | 01/01/2021 |
Eil Therapeutics, Inc.
Eil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for treatment of cancer | Directeur Général | - |
Ness Therapeutics, Inc.
Ness Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for respiratory virus infections | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░ | ░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 25 |
|---|---|
Traws Pharma, Inc.
Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
ChemDiv, Inc.
ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a discovery and development contract research organization | Commercial Services |
Avineuro Pharmaceuticals, Inc.
Avineuro Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for neurological and psychiatric disorders | Health Technology |
Moscow Institute of Physics & Technology
Moscow Institute of Physics & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Finance |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
Chemical Diversity Research Institute CJSC
Chemical Diversity Research Institute CJSC Founded in 1998, Chemical Diversity Research Institute CJSC is a Russian full-cycle pharmaceutical company specializing in the research, development, and production of innovative and generic active pharmaceutical substances (APIs) and finished dosage forms such as tablets, capsules, and injectables. The company is based in Khimki, Russian Federation. The company operates across multiple therapeutic areas including oncology, autoimmune, infectious, neurological, metabolic, orphan diseases, and transplantology. Its team conducts comprehensive pharmaceutical development services, including API discovery and synthesis, mechanistic and pharmacological studies, preclinical and clinical research, pharmacokinetics, product registration, technology transfer, and contract manufacturing. The manufacturing facilities comply with international GMP standards and include workshops for cytostatics, sterile injectables, solid dosage forms, and packaging lines. The company maintains a robust pharmaceutical quality system, is licensed and certified by Russian authorities, and operates pharmacovigilance services to monitor drug safety and manage adverse reaction reports. | |
Viriom Ltd.
Viriom Ltd. Medical/Nursing ServicesHealth Services Develops targeted medicines for HIV/AIDS treatment | Health Services |
ChemRar High-Tech Center
ChemRar High-Tech Center Financial ConglomeratesFinance Provides investment services to biotech start-ups and research and development companies | Finance |
TeaRx Ltd. | |
NewVac LLC
NewVac LLC Medical/Nursing ServicesHealth Services Develops cancer therapy methods | Health Services |
SatRx LLC
SatRx LLC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical and pre-clinical development services | Health Technology |
Chromis Therapeutics, Inc.
Chromis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Commercial Services |
Alla Chem LLC
Alla Chem LLC Pharmaceuticals: MajorHealth Technology Develop pharmaceutical products | Health Technology |
Teal Ventures Management LLC
Teal Ventures Management LLC Investment ManagersFinance Teal Ventures invests in companies located in the United States primarily in Southern California, Northern California and Boston/Cambridge. The firm targets companies operating in the fields of digital technology, data science, medical devices, software-as-a-service and online education. It participates in angel / seed and early capital transactions in the form of equity and convertible debt also makes co-investments. | Finance |
Teal Ventures LP Fund I LP
Teal Ventures LP Fund I LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Viriom, Inc.
Viriom, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antiviral and cancer medicines | Health Technology |
Lomond Therapeutics, Inc.
Lomond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company for treating hematological cancers | Health Technology |
Eil Therapeutics, Inc.
Eil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for treatment of cancer | Health Technology |
Ness Therapeutics, Inc.
Ness Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for respiratory virus infections | Health Technology |
Bala Therapeutics, Inc.
Bala Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a oncology healthcare company | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
Venetian-1 Acquisition Corp.
Venetian-1 Acquisition Corp. Pharmaceuticals: MajorHealth Technology Develops medicines for hematological malignancies | Health Technology |
Trawsfynydd Therapeutics, Inc.
Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing antiviral medicines | Commercial Services |
Eilean Therapeutics LLC
Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in discovery and development of small molecule inhibitors therapies for hematological cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national